Cargando…

Complement Activation in Patients With Diabetic Nephropathy

INTRODUCTION: Complement activation plays a role in various organs in patients with diabetes. However, in diabetic nephropathy (DN), the role of complement activation is poorly understood. We examined the prevalence and clinical significance of complement deposits in the renal tissue of cases with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bus, Pascal, Chua, Jamie S., Klessens, Céline Q.F., Zandbergen, Malu, Wolterbeek, Ron, van Kooten, Cees, Trouw, Leendert A., Bruijn, Jan A., Baelde, Hans J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932121/ https://www.ncbi.nlm.nih.gov/pubmed/29725633 http://dx.doi.org/10.1016/j.ekir.2017.10.005

Ejemplares similares

Endoglin Promotes Myofibroblast Differentiation and Extracellular Matrix Production in Diabetic Nephropathy
por: Gerrits, Tessa, et al.
Publicado: (2020)

The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes
por: Bus, Pascal, et al.
Publicado: (2017)

The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition
por: van Aanhold, Cleo C. L., et al.
Publicado: (2022)

Glomerular clusterin expression is increased in diabetic nephropathy and protects against oxidative stress-induced apoptosis in podocytes
por: He, Junling, et al.
Publicado: (2020)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Nephrin Loss Can Be Used to Predict Remission and Long-term Renal Outcome in Patients With Minimal Change Disease
por: van de Lest, Nina A., et al.
Publicado: (2017)

Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population
por: Gaya da Costa, Mariana, et al.
Publicado: (2018)

Endothelial Endothelin Receptor A Expression Is Associated With Podocyte Injury and Oxidative Stress in Patients With Focal Segmental Glomerulosclerosis
por: van de Lest, Nina A., et al.
Publicado: (2021)

Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease
por: Gerrits, Tessa, et al.
Publicado: (2022)

C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation
por: Trouw, Leendert A., et al.
Publicado: (2005)

Intrinsic carnosine metabolism in the human kidney
por: Peters, Verena, et al.
Publicado: (2015)

Dietary restriction and fasting downregulate complement activity
por: Shushimita, Shushimita, et al.
Publicado: (2012)

Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study
por: de Vos, Thijs W., et al.
Publicado: (2021)

Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Avenues
por: Oltean, Sebastian, et al.
Publicado: (2017)

Genetic associations in diabetic nephropathy: a meta-analysis
por: Mooyaart, A. L., et al.
Publicado: (2010)

Erratum to: Genetic associations in diabetic nephropathy: a meta-analysis
por: Mooyaart, A. L., et al.
Publicado: (2013)

Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains
por: Abendstein, Leoni, et al.
Publicado: (2023)

Thrombomodulin is upregulated in the kidneys of women with pre-eclampsia
por: van Aanhold, Cleo C. L., et al.
Publicado: (2021)

Complement activation in IgA nephropathy
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021)

Targeting complement in IgA nephropathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023)

Podocytes and Proteinuria in ANCA-Associated Glomerulonephritis: A Case-Control Study
por: van Daalen, Emma E., et al.
Publicado: (2019)

Association Between CNDP1 Genotype and Diabetic Nephropathy Is Sex Specific
por: Mooyaart, Antien L., et al.
Publicado: (2010)

Anti-C1q Autoantibodies, Novel Tests, and Clinical Consequences
por: Mahler, Michael, et al.
Publicado: (2013)

Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome
por: Foltyn Zadura, Anna, et al.
Publicado: (2012)

PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation
por: Noone, Dylan P., et al.
Publicado: (2022)

Complement Pathways in Membranous Nephropathy: Complex and Multifactorial
por: Brglez, Vesna, et al.
Publicado: (2020)

Proteomic Analysis of Complement Proteins in Membranous Nephropathy
por: Ravindran, Aishwarya, et al.
Publicado: (2020)

MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023)

Immunoglobulin-binding Sites of Human FcαRI (CD89) and Bovine Fcγ2R Are Located in their Membrane-distal Extracellular Domains
por: Craig Morton, H., et al.
Publicado: (1999)

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
por: Rizk, Dana V., et al.
Publicado: (2019)

Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

Increased dynamin expression precedes proteinuria in glomerular disease
por: Khalil, Ramzi, et al.
Publicado: (2018)

Systemic complement activation in central serous chorioretinopathy
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Inverse correlation between serum complement component C1q levels and whole blood type‐1 interferon signature in active tuberculosis and QuantiFERON‐positive uveitis: implications for diagnosis
por: Schrijver, Benjamin, et al.
Publicado: (2020)

Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cells
por: van Essen, Mieke F., et al.
Publicado: (2022)

Regulating complement in the kidney: insights from CFHR5 nephropathy
por: Gale, Daniel P., et al.
Publicado: (2011)

Complement activation products in the circulation and urine of primary membranous nephropathy
por: Zhang, Mu-fan, et al.
Publicado: (2019)

Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy
por: Pelletier, Karyne, et al.
Publicado: (2019)

Establishing a Case for Anti-complement Therapy in Membranous Nephropathy
por: Ayoub, Isabelle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ifllr4373kee5ldsualdnbg8gk